权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The Role of Intermediate Conformations in G Protein-coupled Receptor Signaling

中间构象在 G 蛋白偶联受体信号传导中的作用

基本信息

批准号：
10635763
负责人：
Libin Ye
金额：
$ 29.9万
依托单位：
UNIVERSITY OF SOUTH FLORIDA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-04-01 至 2027-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10635763
关键词：
ADORA2A gene Affinity Agonist Binding Biological Assay Biophysics Cells Characteristics Communities Complex Coupling Cryoelectron Microscopy Cyclic AMP Data Development Dissociation Drug Design G Protein-Coupled Receptor Signaling G-Protein-Coupled Receptors GTP-Binding Proteins Gases Genetic Guanosine Triphosphate Guanosine Triphosphate Phosphohydrolases Hydrolysis In Vitro Individual Label Lead Ligands Link Maps Measures Mental Depression Modeling Molecular Conformation NMR Spectroscopy Nature Nuclear Magnetic Resonance Nucleotides Outcome Output Parkinson Disease Peptides Play Positioning Attribute Production Protein Conformation Proteins Receptor Activation Relaxation Research Resolution Role Signal Transduction Sodium Chloride Structure Testing Work conformational conversion drug discovery experimental study gas dynamics inhibitor innovation insight interfacial molecular dynamics mutant neuropsychiatric disorder pharmacologic protein activation radioligand receptor response side effect stoichiometry structural biology therapeutic target tool transmission process unnatural amino acids

项目摘要

Project Summary G protein-coupled receptors (GPCRs) can be activated by partial agonists, resulting in submaximal signaling with reduced side effects, compared to the full agonist. Increased studies have indirectly demonstrated that partial agonists stabilize intermediate conformational states between the inactive and fully activated states with a reduced heterotrimeric Gabg protein coupling activity from the fully activated state. Due to the technical hurdles in delineating GPCR conformational states and populating individual intermediate states to study them individually, a mechanistical understanding of partial agonism signaling has been challenging. By creating conformation-biased mutants, we identified five adenosine A2A receptor (A2AR) conformational states, including two inactive states (S1 and S2), two intermediate states (S3 and S4), and a fully active state (S5), using 19F nuclear magnetic resonance (NMR) spectroscopy. This result is a significant advancement to previous research. The R291A mutant predominantly accumulates the intermediate S4 state while the R291AR293A mutant populates both intermediate S3 state and the full activated state S5. This finding enables us to study the roles of these intermediates and their complexes. We will use these two mutants to examine the roles of intermediate states S3 and S4 and their interactions with G proteins and consequent signaling effects. In Aim 1, we will characterize whether and how the intermediate states S3 and S4 interact with Gasbg. These characterizations will include the study of conformational transitions and dynamics of intermediate states and the effects of Gasbg and ligands on their transitions and dynamics. In Aim 2, we will map the conformational states of the Gas and determine its intermediate states that interact with the S3 and S4 states of the A2AR. In Aim 3, we will determine if the intermediate states S3 and S4 of the A2AR induce Gasbg states that are competent for GTP hydrolysis, G protein dissociation, and contribution to submaximal signaling without the S5 state being involved. We expect to correlate conformational and dynamic characteristics of the intermediate states of the A2AR and Gas protein created from Aims 1 and 2 to the signaling efficacies of conformation-biased mutants with ligand stoichiometries, measured in Aim 3. The completion of this proposed project will advance our understanding of the roles that intermediate conformations play in GPCR signaling, lead to a conceptual innovation in understanding receptor activation beyond a simple two-state model, and potentially guide drug design based on GPCR and G protein conformational responses to ligands. Moreover, the conformation-biased mutants will guide an approach development in resolving the structures of intermediate complexes.

项目总结